Clinical Value of Combined CRP and PCT Testing in Differentiating Bacterial from Viral Infections

Background: Differentiating between viral and bacterial illnesses is essential for efficient clinical therapy and minimizing drug abuse.Aim: This study evaluates the clinical value of Procalcitonin (PCT) and C-reactive proteins (CRP) testing used to identify unique bacterial and viral Acute Respiratory Diseases (ARDs) infections.Methodology:142 children with verified bacterium illness were classed as group I, whereas 78 children with a viral illness were classified as group II.Both groups' PCT and CRP values were clinically identified and comparatively analyzed.The clinical tests used to identify biomarkers of the PCT and CRP are the Electrochemiluminescence Immunoassay (ECLIA) for PCT biomarkers and the latex Immunoturbidimetry test for CRP biomarkers.The ANOVA and t-test are used to ZKG INTERNATIONAL